Healthcare & Life Sciences
Mitralign
United Statesmitralign.com
Mitralign is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Mitralign
Based in the United States, Mitralign is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Mitralign developed a minimally invasive medical device technology intended to treat mitral valve regurgitation by reshaping the heart's mitral valve annulus.
Explore Mitralign's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.